BioAdvance News Portfolio News Vesteck

VESTECK, Inc. Closes $5.95 M Series A Preferred equity round

By WebmasterJanuary 4, 2022November 1st, 2024No Comments

VESTECK, Inc. Closes $5.95 M Series A Preferred equity round

Previous PostAnnovis Bio Announces Official Unique Name Buntanetap for Lead Candidate ANVS401
Next PostRelmada Therapeutics Announces Publication of REL-1017 Phase 2 Study Results in The American Journal of Psychiatry